LPL Financial LLC Buys 51,490 Shares of Pediatrix Medical Group, Inc. $MD

Key Points

• LPL Financial LLC increased its stake in Pediatrix Medical Group by 55.5% during the first quarter, holding 144,318 shares valued at approximately $2.09 million.
• Research firms have raised their ratings and price targets for Pediatrix, with a consensus target price now at $16.75 and the stock holding an average rating of "Moderate Buy."
• Pediatrix Medical Group reported a net margin of 5.66% for the last quarter, with revenues of $468.84 million, slightly beating analyst forecasts but down 7.1% compared to the previous year.

LPL Financial LLC boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 55.5% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 144,318 shares of the company's stock after purchasing an additional 51,490 shares during the quarter. LPL Financial LLC owned about 0.17% of Pediatrix Medical Group worth $2,091,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of the company. XTX Topco Ltd bought a new stake in shares of Pediatrix Medical Group during the 4th quarter worth $169,000. Principal Financial Group Inc. lifted its position in Pediatrix Medical Group by 6.2% during the 1st quarter. Principal Financial Group Inc. now owns 586,190 shares of the company's stock worth $8,494,000 after acquiring an additional 34,266 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after acquiring an additional 1,765 shares during the period. SG Americas Securities LLC grew its position in shares of Pediatrix Medical Group by 194.0% in the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after purchasing an additional 25,343 shares during the last quarter. Finally, Deutsche Bank AG grew its position in shares of Pediatrix Medical Group by 53.1% in the fourth quarter. Deutsche Bank AG now owns 74,023 shares of the company's stock valued at $971,000 after purchasing an additional 25,663 shares during the last quarter. Institutional investors own 97.71% of the company's stock.

Analyst Ratings Changes

Several brokerages recently weighed in on MD. UBS Group increased their target price on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research note on Thursday, August 14th. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a report on Monday, August 11th. Finally, Macquarie increased their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and four have assigned a Hold rating to the company's stock. According to MarketBeat, Pediatrix Medical Group currently has an average rating of "Moderate Buy" and an average target price of $16.75.

Pediatrix Medical Group Stock Performance

Shares of MD stock traded up $0.8230 during mid-day trading on Friday, reaching $16.9730. The stock had a trading volume of 1,202,404 shares, compared to its average volume of 889,355. The firm has a market cap of $1.48 billion, a PE ratio of 13.16 and a beta of 1.21. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. Pediatrix Medical Group, Inc. has a one year low of $10.06 and a one year high of $17.67. The firm's 50 day simple moving average is $13.76 and its 200 day simple moving average is $13.94.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, beating analysts' consensus estimates of $0.42 by $0.11. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The business had revenue of $468.84 million during the quarter, compared to analyst estimates of $464.37 million. During the same period in the prior year, the company posted $0.34 earnings per share. Pediatrix Medical Group's revenue was down 7.1% on a year-over-year basis. On average, analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.